204 related articles for article (PubMed ID: 3343610)
1. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.
Levin VA; Rodriguez LA; Edwards MS; Wara W; Liu HC; Fulton D; Davis RL; Wilson CB; Silver P
J Neurosurg; 1988 Mar; 68(3):383-7. PubMed ID: 3343610
[TBL] [Abstract][Full Text] [Related]
2. Low-dose craniospinal radiation therapy for medulloblastoma.
Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
[TBL] [Abstract][Full Text] [Related]
3. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
4. An audit of craniospinal irradiation for medulloblastoma in Newcastle 1970-1992.
Tinkler D; Lucraft HH
Clin Oncol (R Coll Radiol); 1995; 7(3):179-83. PubMed ID: 7547521
[TBL] [Abstract][Full Text] [Related]
5. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
6. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
[TBL] [Abstract][Full Text] [Related]
8. [Results of radiation therapy for medulloblastoma].
Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
[TBL] [Abstract][Full Text] [Related]
9. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
[TBL] [Abstract][Full Text] [Related]
10. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
11. The change in patterns of relapse in medulloblastoma.
Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
[TBL] [Abstract][Full Text] [Related]
12. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
[TBL] [Abstract][Full Text] [Related]
13. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F
J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048
[TBL] [Abstract][Full Text] [Related]
14. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
15. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
16. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
[TBL] [Abstract][Full Text] [Related]
17. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of conformal radiation therapy for medulloblastoma.
Merchant TE; Happersett L; Finlay JL; Leibel SA
Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
[TBL] [Abstract][Full Text] [Related]
19. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]